NCT05069415View on ClinicalTrials.gov

Monofocal IOL Visual Outcomes When Targeting Mini Monovision

NACompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

October 4, 2021

Primary Completion Date

November 30, 2022

Study Completion Date

November 30, 2022

Conditions
CataractPresbyopia
Interventions
DEVICE

Eyhance IOL

Intraocular lens replaces the natural lens removed during cataract surgery in both eyes. Target emmetropia OU.

DEVICE

Eyhance IOL

Intraocular lens replaces the natural lens removed during cataract surgery in both eyes. Target mini monovision in the non-dominant eye.

Trial Locations (2)

29464

Carolina Eyecare Physicians, LLC, Mt. Pleasant

34239

Center for Sight, Sarasota

All Listed Sponsors
lead

Carolina Eyecare Physicians, LLC

OTHER

NCT05069415 - Monofocal IOL Visual Outcomes When Targeting Mini Monovision | Biotech Hunter | Biotech Hunter